biotech / news / / Bnn Bloomberg
Hims & Hers Health is now offering Canadians with type 2 diabetes a generic version of semaglutide.
Hims & Hers Health is now offering generic semaglutide to Canadians through its platform.
KEY POINTS
- Apotex's generic semaglutide was approved by Health Canada and launched as Apo-Semaglutide Injection.
- Dr Reddy’s has also launched a generic semaglutide version in the Canadian market.
- Hims & Hers offers personalized semaglutide treatment plans starting at $149 per month.
COMPANIES
Summarized by Newsio from Bnn Bloomberg. How we summarize →